FEBRUARY 24, 2017 UPDATE
To our A Fair Shot supporters wondering how the progress is going with GSK and Pfizer, we have an update for you! In September and November 2016, GSK and Pfizer (respectively) made commitments to offer humanitarian organizations working in emergencies the lowest global price for the pneumonia vaccine. More than 3 months have passed since the companies made their announcements. As of late February 2017, negotiations with both companies are just beginning. We hope that Pfizer and GSK will deliver on their promises and make the pneumonia vaccine available to children living in emergency contexts as soon as possible.
FEBRUARY 14, 2017
After years of negotiation, Pfizer finally announced in November 2016 that it was reducing the price of its pneumococcal conjugate vaccine, Prevenar 13, (PCV13) to 3.10 per dose (US$ 9.30 per child for all three doses) for humanitarian organizations working in emergency settings. This is definitely a step in the right direction and will help to protect millions of vulnerable children around the world and in MSF projects. We now hope that Pfizer will extend its efforts to developing countries by offering a lower price to all governments which still can’t afford to protect their children against pneumonia. Read More
HELP DOCTORS WITHOUT BORDERS #ASKPHARMA TO LOWER THE PRICE OF THE PNEUMONIA VACCINE.
Thank you for helping us #AskPharma to lower the price of the pneumonia vaccine! Over 416,272 people from 170 countries signed our petition, which was handed to Pfizer and GSK in New York, London, and Madrid.
On April 27, 2016, we carried your voices to Pfizer Headquarters, and they accepted our petition. Now, it's their turn to play their role and drop the price of the pneumonia vaccine to $5/child for all developing countries and humanitarian organizations.
Thank you for taking action with us! This campaign is not over, so stay in touch for the next step!
HERE'S WHY YOU SHOULD CARE
Pneumonia kills nearly 1 million children worldwide each year.
Pfizer & GSK have made a total of $36 billion in sales off the pneumonia vaccine alone.
It costs 68x more to fully immunize a child now than it did in 2001, and the expensive pneumonia vaccine accounts for much of that increase.
60 countries spoke out about high vaccine prices at the World Health Assembly in 2015.
Pfizer and GlaxoSmithKline (GSK) are the only two producers of the life-saving pneumonia vaccine. Many lives have been saved by this vaccine, but pneumonia still kills nearly 1 million children every year.
In fact, 75% of children around the world remain unprotected against pneumonia, the leading infectious cause of childhood death worldwide.
You have the power to help change this.
Only about half of the world’s countries have been able to start using the pneumonia vaccine produced by Pfizer & GSK, known as the pneumococcal conjugate vaccine (PCV). One key barrier is the high price.
Even at the lowest global prices, it costs 68 times more today to vaccinate a child in developing countries than it did in 2001 – nearly half of that increase is due to the high price of the pneumonia vaccine alone. This means that a growing number of developing countries can't afford to buy the pneumonia vaccine to protect their children against this childhood killer.
Pfizer & GSK have collectively reported more than US$28 billion in global sales from this vaccine. That’s almost three times the entire 20-year budget that Gavi, the Vaccine Alliance, uses to provide 10 different vaccines in around 60 of the world’s poorest countries.
MSF has also struggled to get long-term affordable access to the pneumonia vaccine to help vaccinate some of the world’s most vulnerable children in humanitarian crises.
It's time for Pfizer and GSK to lower the price to $5 per child (for all three doses) for all developing countries and humanitarian organizations.
The lowest global price for the pneumonia vaccine is $10 per child (for all three doses), available to only the poorest countries through Gavi. History has shown that with competition, prices will inevitably come down. A producer in India is developing a pneumonia vaccine that it has promised to sell for $6 per child – but it won’t be available until at least 2019. Between now and then, as many as 4 million more children could die because they have not been vaccinated against pneumonia. A more affordable pneumonia vaccine could help reduce this unnecessary loss of life, so why wait any longer to lower the price?
Please help us ask Pfizer & GSK to put children's lives over more blockbuster revenues. Today, children are being left unprotected in countries such as Indonesia, Iraq, Jordan, Lebanon, Romania, Syria and Thailand, among many others. A child dies of pneumonia every 35 seconds.
Now's the time to lower the price of the pneumonia vaccine to $5 per child (for all three doses) for all developing countries and humanitarian organizations, so more lives can be saved.
Together we can do this.
OUR VACCINATION CAMPAIGNS
Sign up with your email address to receive news and updates: